Highlights of the 2026 Korean Society of Hypertension guidelines for the management of hypertension: what's new and what has changed - PubMed
3 hours ago
- #Hypertension Management
- #Medical Guidelines
- #Blood Pressure Control
- The 2026 Korean Society of Hypertension (KSH) guidelines now include isolated diastolic hypertension in blood pressure classification.
- Cuffless blood pressure devices are integrated into clinical practice for the first time in these guidelines.
- New therapies with blood pressure-lowering effects are incorporated, such as angiotensin receptor-neprilysin inhibitors and sodium-glucose cotransporter 2 inhibitors.
- A dose-based classification for single-pill combination therapies is introduced to improve treatment adherence.
- Obesity, hypertension in young adults, hypertensive emergencies, and patient-centered care are newly emphasized areas.
- Updated recommendations include expanded screening for primary aldosteronism and more intensive blood pressure targets.
- Lifestyle advice now covers e-smoking cessation and mind-body practices.
- Management of uncontrolled hypertension is refined, and blood pressure targets in older adults are individualized based on frailty.
- Blood pressure management during pregnancy emphasizes active control below 140/90 mmHg and out-of-office measurements.